GLAXO
GLAXOSMITHKLINE PHARMA LT

2332.0 +67.71 (+2.9%)

Waiting to invest in GLAXO? Consider at the moment as it outperformed the broader market

19 Jun, 20265 min read

GLAXO outperformed the broader market today. On a longer term basis, investors in GLAXOSMITHKLINE PHARMA LT made +0.03% per day. Friday's performance of +2.9% was a outperformance compared to it's daily average.

Want to improve your Portfolio's performance?
Spotalpha's Portfolio optimizer is all you need to improve your returns and reduce your risk.
Optimize Portfolio NOW
Read analysis
Following
Symbol Price {{retType}} | Tr.
{{detail.symbol}} {{detail.close}} {{detail.priceChange}}  {{detail.pctChange}}%  {{detail.name}} {{detail.trend}}